Reuters logo
BRIEF-Aspen to not comment on allegations in press reports
April 18, 2017 / 6:17 AM / 5 months ago

BRIEF-Aspen to not comment on allegations in press reports

April 18 (Reuters) - Aspen Pharmacare Holdings Limited :

* Aspen’S response to the press reports of 14 and 15 April 2017

* Demonstrated commitment to providing medicines affordably over many years, supply of oncology products in question is no exception

* Aspen will not comment on these public allegations

* Aspen looks forward to opportunity to demonstrate integrity and legality of its practices in context of these legal processes.

* Oncology portfolio in question generated revenue in EU in Aspen’s FY ended 30 June 2016 of EUR 60 million (963 mln rand) Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below